See All Slides - tctmd.com

Slides

Presentation TCT 2015

Physiological Assessment in Multivessel Disease: What Will SYNTAX 2 and FAME 3 Tell Us?

Presenter: Sergio B Baptista, Eric Van Belle, Bernard De Bruyne

October 12, 2015

Presentation TCT 2015

Aortic Stenosis With Extreme Comorbidities (the Futile Patient): Case Presentation

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Neal S. Kleiman

October 12, 2015

Presentation TCT 2015

Congenital Heart Disease: PFO, ASD, VSD, and PDA

Presenter: Harsimran Sachdeva Singh, John P. Breinholt

October 12, 2015

Presentation TCT 2015

Coherex WaveCrest and the WAVECREST 2 Randomized Trial

Presenter: Brij Maini, Horst Sievert, Brian K. Whisenant

October 12, 2015

Presentation TCT 2015

Next-Generation DCBs: Alternative Coatings and Drug-Delivery Platforms for SFA Intervention

Presenter: Krishna J. Rocha-Singh, Andrej Schmidt, Juan F. Granada

October 12, 2015

Presentation TCT 2015

LoneStar Heart: Description and Clinical Update

Presenter: Ileana L. Pina, James E. Udelson, Joost Daemen

October 12, 2015

Presentation TCT 2015

Device and Clinical Program Highlights: Orsiro

Presenter: Pieter C. Smits, Philip M. Urban, Thomas Pilgrim

October 12, 2015

Presentation TCT 2015

Debate: What Is the Optimal ADP-Antagonist Preloading Approach in STEMI? Cangrelor!

Presenter: Eric Boersma, E. Magnus Ohman, Deepak L. Bhatt

October 12, 2015

Presentation TCT 2015

Severe Renal Disease and TAVR: Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Charles J. Davidson

October 12, 2015

Presentation TCT 2015

Scotland Presents: How Did I Treat This Case?

Presenter: Graham A. Cassel, Nick Curzen, Niall T. Mulvihill, Margaret B. McEntegart

October 12, 2015

Advertisement

Slides

Physiological Assessment in Multivessel Disease: What Will SYNTAX 2 and FAME 3 Tell Us?

Aortic Stenosis With Extreme Comorbidities (the Futile Patient): Case Presentation

Congenital Heart Disease: PFO, ASD, VSD, and PDA

Coherex WaveCrest and the WAVECREST 2 Randomized Trial

Next-Generation DCBs: Alternative Coatings and Drug-Delivery Platforms for SFA Intervention

LoneStar Heart: Description and Clinical Update

Device and Clinical Program Highlights: Orsiro

Debate: What Is the Optimal ADP-Antagonist Preloading Approach in STEMI? Cangrelor!

Severe Renal Disease and TAVR: Thoughtful Commentary on the Case

Scotland Presents: How Did I Treat This Case?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content